Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page shows a new revision tag, updating from v3.5.3 to v3.5.4. This indicates the study record was updated to a newer revision without substantive changes to the displayed content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe Denmark location listing was updated to reflect “Region Sjælland,” including the Næstved address line, replacing the previous “Zeeland” wording. This is a administrative/labeling correction to the study sites rather than a change to the trial itself.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded a publication citation for the EMERALD trial (JCO 2022). Removed an Erratum entry related to that publication.SummaryDifference0.0%

- Check95 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2. No substantive changes to the study details or page layout are observed.SummaryDifference0.0%

- Check103 days agoChange DetectedPublication reference updated: EMERALD JCO 2022 article added with Erratum and older version removed. Page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.